Amgen Inc (AMGN)

AMGN (NASDAQ:Drugs)
$122.26
pos +0.25
+0.20%
Today's Range: 121.32 - 122.36 | AMGN Avg Daily Volume: 3,166,700
Last Update: 07/24/14 - 4:00 PM EDT
Volume: 2,709,220
YTD Performance: 6.95%
Open: $122.15
Previous Close: $122.01
52 Week Range: $103.31 - $128.96
Oustanding Shares: 757,021,648
Market Cap: 89,109,018,186
6-Month Chart
TheStreet Ratings Grade for AMGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 8 8 7
Moderate Buy 1 1 1 0
Hold 10 10 10 11
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.21 2.08 2.08 2.22
Latest Dividend: 0.61
Latest Dividend Yield: 2.01%
Dividend Ex-Date: 05/13/14
Price Earnings Ratio: 19.66
Price Earnings Comparisons:
AMGN Sector Avg. S&P 500
19.66 19.10 28.87
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
7.67% 14.43% 120.95%
GROWTH 12 Mo 3 Yr CAGR
Revenue 8.20 0.24 0.07
Net Income 16.90 0.10 0.03
EPS 20.30 0.40 0.12
Earnings for AMGN:
EBITDA 7.35B
Revenue 18.68B
Average Earnings Estimates
Qtr (06/14) Qtr (09/14) FY (12/14) FY (12/15)
Average Estimate $1.99 $2.09 $8.10 $8.78
Number of Analysts 3 3 3 3
High Estimate $2.03 $2.15 $8.18 $9.04
Low Estimate $1.93 $2.02 $7.99 $8.56
Prior Year $1.88 $1.93 $7.57 $8.10
Growth Rate (Year over Year) 5.67% 8.29% 6.96% 8.48%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Carolyn Boroden

 | Jun 27, 2014 | 9:00 AM EDT

On a daily time frame, as long as it holds a key support level, it's a possible buy.

By

David Katz

 | Jun 20, 2014 | 11:00 AM EDT

Hologic, Symantec and TE Connectivity could all benefit from the current M&A binge.

By

Dan Fitzpatrick

 | Jun 11, 2014 | 11:30 AM EDT

For now, just let the market do the heavy lifting for you.

By

Ed Ponsi

 | May 28, 2014 | 10:30 AM EDT

After a decline, the sector has built a base, and these names are breaking out.

By

David Katz

 | May 16, 2014 | 12:00 PM EDT

Spice up your portfolio with some takeover bait.

By

David Katz

 | May 6, 2014 | 2:30 PM EDT

Its pipeline appears strong enough to overcome patent-expiration issues.

By

Carolyn Boroden

 | Apr 27, 2014 | 6:00 PM EDT

If the stock doesn't breach support, here's where I'd buy in.

By

Paul Price

 | Apr 25, 2014 | 10:30 AM EDT

Their peak prices were out of line -- not the subsequent selloffs.

bearishAmgen estimates, target cut at Nomura

Apr 23, 2014 | 8:15 AM EDT

Shares of AMGN now seen reaching $129, according to Nomura. Estimates also reduced, as the company lacks visibility with its latest guidance. Neutral rating.

bearishAmgen price target, EPS cut at Jefferies

Apr 23, 2014 | 7:20 AM EDT

AMGN lowered its numbers, Jefferies said. Lower product sales impacted by historical patterns and inventory drawdown. $142 price target and Buy rating. 

FB is trading $75.88, up 6.4% with IV30™ down 33.4%. This is a follow up to the post...
Bloomberg reporting around 2pm ET Zillow for Trulia...Z declined to comment, TRLA won't co...
With just over 40% of S&P 500 components having reported 2Q earnings, 158 of them or a...
DHI is the biggest loser in the S&P 500 today. The homebuilder is off over 10% on...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.